Osciflex LLC

Philadelphia, PA

UEI
DAEHRJE6P7N4
CAGE
81P75
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
Working Dog Center, 3401 Grays Ferry Ave #1023, Philadelphia, PA 19146, USA
Website
osciflex.com
Founded
2017
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sbir phase II: a portable rapid cycling compression device to prevent blood clots 2132561 Division of Industrial Innovation $999,727
Mechanical device for the prevention of VTE in high risk patient populations - principal investigator: welsh, john d… R44HL145860 National Heart Lung and Blood Institute (NIH) $5,370,500
Mechanical generation of peri-valvular oscillatory flow to prevent deep venous thrombosis. R41HL145860 National Heart Lung and Blood Institute (NIH) $149,265
Sbir phase i: VTE mitigation device 1842867 Division of Industrial Innovation $225,000

Similar vendors

Vendor Location Primary NAICS
W-Z Biotech LLC UEI RK1ZDCXE3LJ7 Lexington, KY 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Bridgesource Medical, Corp. UEI TJWEFWAH8JK6 Austin, TX 541330 Engineering Services
Translational Sciences Inc. UEI EFQDNXDDTBM4 Paradise Valley, AZ 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Flobio LLC UEI YPEYKCYZB837 Wayne, PA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Kilele Health Inc. UEI YYQ9GCP29EA1 Dayton, OH —

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Osciflex LLC is a for-profit limited liability company that develops medical devices, specifically a portable rapid cycling compression device to prevent blood clots. Through federal grants from the National Science Foundation Division of Industrial Innovation and National Institutes of Health National Heart Lung and Blood Institute, Osciflex has received funding to support the development, testing, and commercialization of this medical device.

Specifically, Osciflex has been awarded federal grants totaling over $6 million to develop a mechanical device that generates peri-valvular oscillatory venous blood flow to prevent deep vein thrombosis and pulmonary embolisms. This includes Phase I and Phase II SBIR awards from the NSF to develop and commercialize a prototype VTE mitigation device, as well as project grants from the NHLBI to further research and optimize the device design through collaborations with clinicians, engineers, and human factors experts. The end goal is to complete requisite testing and modifications to support prolonged human use and regulatory approval to conduct decisive clinical trials on the safety and efficacy of the device. Osciflex's portable rapid cycling compression device aims to restore natural anti-thrombotic blood flow mechanisms to prevent blood clots and related cardiovascular complications.

Quick answers

Is Osciflex LLC registered in SAM.gov?

Yes. Osciflex LLC's SAM.gov registration is active through December 9, 2026.

What is Osciflex LLC's most recent federal award?

Osciflex LLC's most recent federal grant award is Sbir phase II: a portable rapid cycling compression device to prevent blood clots (2132561), from Division of Industrial Innovation, on October 15, 2021.

On GovTribe

See Osciflex LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login